The orexigenic action of ghrelin is based on increasing gastrointestinal peristalsis and reducing insulin secretion, and despite its appetite stimulation effects, it was found that obesity, type 2 diabetes mellitus and metabolic syndrome are associated with lower serum ghrelin concentrations [7, 8, 11]. The gene discussed is GHRL; the disease is metabolic syndrome.